Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Clinical trial NCT00860639 · COMPLETED
Trial details
- NCT number
- NCT00860639
- Sponsor
- Nantes University Hospital
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2016-09-26
- Enrollment
- 327
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.